The stronger correlation of neurogranin and tau/p-tau in non-AD patients as compared with patients with AD and the missing elevation of neurogranin in non-AD-D patients also points to a mechanism of neurodegeneration in AD distinct from the physiological dying of neurons and distinct from other neurodegenerative diseases. The gene discussed is MAPT; the disease is Alzheimer disease.